Carisma Therapeutics Inc. Deferred Tax Liabilities, Net
Carisma Therapeutics Inc. had Deferred Tax Liabilities, Net of $0 as of 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilities · last filed 2023-02-28
- 2022-12-31: Deferred Tax Liabilities, Net $0.00.
- 2021-12-31: Deferred Tax Liabilities, Net $3.97M.
- 2020-12-31: Deferred Tax Liabilities, Net $12.53M.
- 2019-12-31: Deferred Tax Liabilities, Net $12.53M.
| Period end | Deferred Tax Liabilities, Net |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-28 |
| 2021-12-31 | $3.97M 10-K · filed 2023-02-28 |
| 2020-12-31 | $12.53M 10-K · filed 2023-02-28 |
| 2019-12-31 | $12.53M 10-K · filed 2022-02-28 |
| 2018-12-31 | $12.53M 10-K · filed 2020-03-16 |
| 2017-12-31 | $12.53M 10-K · filed 2019-03-01 |
| 2016-12-31 | $16.34M 10-K · filed 2018-04-02 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-24 |